1. What Is BPC-157
BPC-157 (Body Protection Compound-157) is a synthetic peptide consisting of 15 amino acids. It is derived from a protective protein found naturally in human gastric juice. The peptide has been the subject of extensive preclinical research, primarily in animal models, investigating its potential effects on tissue repair and healing.
BPC-157 is one of the most widely discussed peptides in the research compound market. Its popularity stems from a substantial body of animal research suggesting effects across multiple tissue types — muscle, tendon, ligament, bone, and gastrointestinal tissue.
2. Mechanism of Action
The mechanisms through which BPC-157 exerts its effects are not fully understood, but published research has proposed several pathways:
Angiogenesis
Multiple animal studies have reported that BPC-157 promotes the formation of new blood vessels (angiogenesis), which is a key factor in wound healing and tissue repair. This has been observed in studies on tendon, muscle, and intestinal healing.
Growth Factor Modulation
Research suggests BPC-157 may influence growth factor expression, including VEGF (Vascular Endothelial Growth Factor) and FGF (Fibroblast Growth Factor), both of which play roles in tissue regeneration.
Nitric Oxide System
Several studies indicate BPC-157 interacts with the nitric oxide (NO) system, which is involved in blood flow regulation, inflammation, and cytoprotection in the gastrointestinal tract.
Anti-inflammatory Effects
Animal models have shown reduced inflammatory markers in tissues treated with BPC-157, though the precise anti-inflammatory mechanism remains under investigation.
3. Research Evidence
The body of published research on BPC-157 is substantial relative to most research peptides. Key areas of study include:
4. What the Research Does Not Show
It is critical to understand the limitations of the current evidence:
- Almost all published research is in animal models — primarily rats and mice. Animal results do not reliably predict human outcomes. Mechanisms that work in rodents frequently fail to translate to humans.
- Human clinical trial data is extremely limited. As of September 2026, there are no large-scale, peer-reviewed, randomized controlled trials of BPC-157 in humans published in major journals.
- Long-term safety data does not exist. No studies have evaluated the effects of prolonged BPC-157 use in humans. The safety profile beyond short-term animal studies is unknown.
- BPC-157 is not approved by the FDA, Health Canada, or the EMA for any medical use. It is sold as a research compound.
- Angiogenesis promotion is a double-edged mechanism. While beneficial for wound healing, promoting blood vessel formation is a concern in the context of existing tumors or cancer risk. This has not been adequately studied.
5. Purity and Lab Testing
BPC-157 is a 15-amino-acid peptide with a molecular weight of approximately 1419.53 Da. When evaluating lab results for BPC-157, here is what to expect:
HPLC Purity
Research-grade BPC-157 from reputable suppliers typically tests at 98% or above via HPLC. Purity below 95% is uncommon for finished retail products and may indicate a lower-grade synthesis or degradation.
Mass Spectrometry
The observed molecular weight should match approximately 1419.53 Da (the average molecular weight; the monoisotopic mass is about 1418.7 Da). This confirms the peptide is BPC-157 and not a truncated or incorrect sequence. A discrepancy of more than 1-2 Da warrants scrutiny.
Stability Considerations
BPC-157 is relatively stable compared to many peptides, but it is still sensitive to heat, light, and moisture once reconstituted. COA results reflect the purity at the time of testing — improper storage after testing can degrade the product below the reported purity.
6. What to Look For in a BPC-157 COA
When evaluating a COA for a BPC-157 product, confirm the following:
HPLC purity of 98% or higher from a named, independent third-party lab
Mass spectrometry confirming molecular weight near 1419.53 Da
A batch or lot number that matches the product you received
A lab reference number you can verify directly with the testing lab
Test date — a COA from years ago may not reflect current product quality
For a full walkthrough of evaluating a COA, see our guide to reading a peptide COA.
Summary
BPC-157 is a well-studied research peptide with a large body of animal evidence suggesting tissue-protective and healing properties across multiple systems. However, human clinical data is extremely limited, long-term safety is unknown, and it is not approved for medical use. When evaluating a BPC-157 product, prioritize third-party lab testing showing HPLC purity above 98% and mass spec identity confirmation at approximately 1419.53 Da.